Cargando…
Neonatal mass screening for 21-hydroxylase deficiency
Congenital adrenal hyperplasia(CAH)due to 21-hydroxylase deficiency (21-OHD) is an inherited autosomal recessive disorder. Its incidence is 1 in 10,000 to 20,000 worldwide. This disease shows phenotypic differences, and it is divided into three forms i.e., the salt wasting (SW), simple virilizing (S...
Autores principales: | Tajima, Toshihiro, Fukushi, Masaru |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Japanese Society for Pediatric Endocrinology
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4738187/ https://www.ncbi.nlm.nih.gov/pubmed/26865749 http://dx.doi.org/10.1297/cpe.25.1 |
Ejemplares similares
-
Prenatal Diagnosis and Treatment of Steroid 21-Hydroxylase
Deficiency
por: Tajima, Toshihiro, et al.
Publicado: (2008) -
Health problems of adolescent and adult patients with 21-hydroxylase
deficiency
por: Tajima, Toshihiro
Publicado: (2018) -
Guidelines for diagnosis and treatment of 21-hydroxylase deficiency (2014
revision)
por: Ishii, Tomohiro, et al.
Publicado: (2015) -
Clinical guidelines for the diagnosis and treatment of 21-hydroxylase
deficiency (2021 revision)
por: Ishii, Tomohiro, et al.
Publicado: (2022) -
Pregnanetriolone in paper-borne urine for neonatal screening for 21-hydroxylase deficiency: The place of urine in neonatal screening
por: Alonso-Fernández, José Ramón
Publicado: (2016)